Temaz and Yervoy drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Temaz (temazepam) and Yervoy (ipilimumab). Common drug interactions include fatigue among females and hypotension among males.

The phase IV clinical study analyzes what interactions people have when they take Temaz and Yervoy. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Temaz?

Temaz has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 42,293 Temaz users. Check the latest studies of Temaz.

What is Yervoy?

Yervoy has active ingredients of ipilimumab. eHealthMe is studying from 26,662 Yervoy users. Check the latest studies of Yervoy.

On Aug, 04, 2026

13 people who take Temaz and Yervoy together, and have interactions are studied.

What are the common drug interactions of Temaz and Yervoy, by gender? *:

female:

Fatigue (feeling of tiredness)
Nausea (feeling of having an urge to vomit)
Back pain
Blood sodium decreased
Hypoaesthesia oral (reduced sense of touch or sensation in mouth)
Neoplasm malignant (cancer tumour)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Addison's disease (addison's disease, a hormonal disorder disease)
Adrenocortical insufficiency acute (suddenly adrenal glands do not produce adequate amounts of steroid hormones)
Arthralgia (joint pain)

male:

Hypotension (abnormally low blood pressure)
Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
Cerebral haemorrhage (bleeding within the brain)
Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Malignant neoplasm progression (cancer tumour came back)
Muscular weakness (muscle weakness)
Type 1 diabetes mellitus
Urinary tract infection

What are the common drug interactions of Temaz and Yervoy, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
Type 1 diabetes mellitus

50-59:

Fatigue (feeling of tiredness)
Back pain
Blood sodium decreased
Hypoaesthesia oral (reduced sense of touch or sensation in mouth)
Nausea (feeling of having an urge to vomit)
Neoplasm malignant (cancer tumour)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Addison's disease (addison's disease, a hormonal disorder disease)
Adrenocortical insufficiency acute (suddenly adrenal glands do not produce adequate amounts of steroid hormones)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

60+:

Hypotension (abnormally low blood pressure)
Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
General physical health deterioration (weak health status)
Hepatitis (inflammation of the liver)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Infection
Leukopenia (less number of white blood cells in blood)
Malignant neoplasm progression (cancer tumour came back)
Muscular weakness (muscle weakness)
Myasthenic syndrome (a group of conditions characterized by muscle weakness (myasthenia) that worsens with physical exertion)

What are the existing conditions these people have? *

Metastatic Neoplasm (spreadable cancer tumour): 3 people, 23.08%
Malignant Melanoma (skin cancer rises from melancytes): 3 people, 23.08%
Cervix Carcinoma (cancer of cervix): 3 people, 23.08%
Pain: 2 people, 15.38%
Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 2 people, 15.38%
Lambert-Eaton Syndrome (this means your immune system mistakenly targets healthy cells and tissues in the body): 2 people, 15.38%
Sleep Disorder: 1 person, 7.69%
Parkinson's Disease: 1 person, 7.69%
Nausea (feeling of having an urge to vomit): 1 person, 7.69%
Lung Neoplasm Malignant (cancer tumour of lung): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Temaz and Yervoy?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously